 A U.S. Supreme Court decision involving OxyContin maker Purdue Pharma could cost Delaware $45 million. A Supreme Court rejected a nationwide settlement that would have shielded members of the family who own the company from civil lawsuits over the toll of opioids, but would have provided billions of dollars to combat the epidemic. Among the money, $45 million that Delaware would have received. Attorney General Kathy Jennings said, quote,